about
Natural Compounds Modulating Mitochondrial FunctionsAnti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with PsoriasisAgeing and inflammation in patients with HIV infection.iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles.Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction.Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells.Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.Human dental pulp stem cells (hDPSCs): isolation, enrichment and comparative differentiation of two sub-populations.T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.Immunological advantages of everolimus versus cyclosporin A in liver-transplanted recipients, as revealed by polychromatic flow cytometry.Reliable and accurate CD4+ T cell count and percent by the portable flow cytometer CyFlow MiniPOC and "CD4 Easy Count Kit-Dry", as revealed by the comparison with the gold standard dual platform technology.Quercetin and cancer chemopreventionUncompensated Polychromatic Analysis of Mitochondrial Membrane Potential Using JC-1 and Multilaser Excitation.Quantification of mitochondrial reactive oxygen species in living cells by using multi-laser polychromatic flow cytometry.The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.T cell homeostasis in centenarians: from the thymus to the periphery.Endoscopic third ventriculostomy in obstructive infantile hydrocephalus: remarks about the so-called 'unsuccessful cases'.Cytometry, immunology, and HIV infection: three decades of strong interactions.Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV.Different origin of adipogenic stem cells influences the response to antiretroviral drugs.HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell : CD8+ cell ratio or length of efficient treatment.Mitochondrial Proteases as Emerging Pharmacological Targets.Human dental pulp stem cells expressing STRO-1, c-kit and CD34 markers in peripheral nerve regeneration.Emerging role of Lon protease as a master regulator of mitochondrial functions.Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells.Sirtuin 3 interacts with Lon protease and regulates its acetylation status.Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis.Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes.Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.Functional characterization of the promoter of the human Lon protease gene.Optimized Cryopreservation and Banking of Human Bone-Marrow Fragments and Stem Cells.Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy.Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function.Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly.Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin.Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.
P50
Q28087261-66CEC117-33B1-4941-BD59-ECDE96F8089EQ28554923-DA292204-2BD6-46A4-8672-98522E291A42Q30244296-24BD5C73-A66C-47BC-831F-CFDE00F874FAQ30368046-736D1AE7-E671-449B-9410-C4A515873EE4Q30374603-7740E15B-9E06-40F0-B0A3-EC82D1124A92Q30393445-95068E98-E764-42F8-897E-80019338C19FQ30398970-5133280A-0BD0-477D-AED5-E360397092E3Q30415779-357CE9D5-CD3C-493F-8EA1-E226845BCA23Q34510458-B34F76E1-A470-41BE-835F-4EBA1006418BQ34635688-49FDF36C-D734-4911-9371-1ECD0A76E810Q35013375-C6BEFC9E-CE3D-428A-BD65-493AAC54CE08Q35106541-590B7347-BD87-4305-9EBB-B73CA98485BFQ35591242-CF0BA91D-949C-4041-8AC0-94033491CF72Q36116905-028E9D27-F328-45E5-B490-90A150ED6195Q36967153-9725E7F5-60C2-444F-BD97-EC6132ED1004Q37730121-41021B11-5438-44CA-8BC8-F812AEA46D0AQ37871757-D9574444-68D6-410D-9C75-DCAC8E0D1945Q38115992-8B43E9D3-F834-49BB-9411-97853EEB9B1AQ38226374-987BCF5D-B5C6-4F04-B654-9CEC8D831790Q38559976-41177DC6-B47D-48AB-9600-277556CF9FF4Q38692721-449D5591-5D3A-43D1-B888-FDCFB9945228Q38718482-BACB483F-D52A-46D3-B3FD-F48AF546EF16Q38784001-63F48430-3888-4D3F-A04A-C73A9D24A100Q38795089-007E37EB-7B3D-4FAD-A7AD-62DB4F072EC2Q38963045-2020BD1C-C444-41A7-8ACA-54DE1688194AQ38965419-1B280707-5DF5-490E-8C63-814F2B45577CQ39101567-DA2B0C26-D4A9-4ACB-83AB-0597F93C86FEQ39248387-4E3BEC0C-7949-4E47-BD22-D4D7B70DD97FQ39285583-EFDBDEDB-7102-4BA9-B1BC-FACDC466918EQ39399731-C55E7A7D-5E95-434E-88B9-40B85ECB0686Q39646512-4BD0DDFC-EF7E-4A32-AE66-12A8CC59B499Q40811425-3D2D7CC1-385E-4C18-90C4-1B1369ABF476Q41075388-6ABAC3AB-41EC-4F69-85CB-2D9153AD1EF3Q41608018-5311C08D-3D8E-400D-A74C-4B983649D2C4Q41701694-2A6B0052-6827-431D-8826-EF63F9320870Q41918189-1338DBF8-5CEF-46F3-9E29-1277DECAB36DQ42030945-9BC6DA2E-A48C-498A-B87C-DCF6F9E06C20Q42875767-E30039EC-77B8-480B-A6E9-5151AC45A1E2Q43157239-E3BECBAF-26BD-4632-9D5A-AEA55317D901Q43185882-CC070C42-D776-4BB0-8047-CAA5A6DB858C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sara De Biasi
@en
Sara De Biasi
@nl
type
label
Sara De Biasi
@en
Sara De Biasi
@nl
prefLabel
Sara De Biasi
@en
Sara De Biasi
@nl
P31
P496
0000-0002-3217-9821